Electromagnetic pulses provide pain relief for osteoarthritis
March 5, 2010 by admin · Leave a Comment
Contact: Maria Seyrig
mseyrig1@hfhs.org
313-874-4039
Henry Ford Health System
Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers.
New ’suicide’ molecule halts rheumatoid arthritis
January 27, 2010 by admin · Leave a Comment
Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University Read more
Blood test can predict rheumatoid arthritis before symptoms arise
January 27, 2010 by admin · Leave a Comment
Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell Read more
How arthritis thrives
January 24, 2010 by admin · Leave a Comment
Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University Read more
UT rheumatologists advance genetic research related to disabling form of arthritis
January 9, 2010 by admin · Leave a Comment
Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease. In addition, the international research team pinpointed two areas along stretches of DNA that play an important role in regulating gene activity associated with the arthritic condition.
Enzyme necessary for development of healthy immune system
December 20, 2009 by admin · Leave a Comment
Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by researchers with UCLA’s Jonsson Comprehensive Cancer Center.
Biogen Idec’s oral compound BG-12 achieves development milestones in MS and RA
December 6, 2009 by admin · Leave a Comment
Contact: Tracy Vineis
617-914-6524
GCI Health
CAMBRIDGE, Mass. December 7, 2009 Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA). In recent months, the last patient was enrolled in the CONFIRM trial, the second of two Phase III trials designed to evaluate the efficacy and safety of BG-12 as a monotherapy in patients with relapsing-remitting multiple sclerosis (RRMS). Both the DEFINE and CONFIRM Phase III trials are now fully enrolled and will evaluate the effect of BG-12 on clinical relapse, disability progression, various MRI measures of disease activity, and safety.
How saturated fatty acids ‘anger’ the immune system (and how to stop them)
November 3, 2009 by admin · Leave a Comment
Researchers have new evidence to explain how saturated fatty acids, which soar in those who are obese, can lead the immune system to respond in ways that add up to chronic, low-grade inflammation. The new results could lead to treatments designed to curb that inflammatory state, and the insulin resistance and type 2 diabetes that come with it.
New biologic drug is effective against rheumatoid arthritis
October 6, 2009 by admin · Leave a Comment
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug.
Hormone promises to keep joint injuries from causing long-term osteoarthritis
September 14, 2009 by admin · Leave a Comment
Goal to extend useful life of arthritic knees and hips
An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis, according to an early study presented today at the annual meeting of the American Society for Bone and Mineral Research in Denver. While the study was in mice, the model closely mimics human osteoarthritis that develops following knee injuries, according to the study authors.
